Bacil Pharma Key Metrics

BSE: 524516 | NSE: - | ISIN: INE711D01018 | Sector: Biotechnology & Drugs

45.17 +0.87 (1.96%)Updated : 26 Nov 2024

Ratios

Return on average equity - 5 year average	-
Net Income/employee - trailing 12 month	12,84,157.00
Revenue/employee - most recent fiscal year	-
Return on investment - most recent fiscal year	-5.11
Return on average assets - most recent fiscal year	-4.81
Receivables turnover - most recent fiscal year	-
Return on investment - trailing 12 month	26.27
Return on average assets - trailing 12 month	24.50
Inventory turnover - most recent fiscal year	-
Inventory turnover - trailing 12 month	-
Revenue/employee - trailing 12 month	0.00
Return on average assets - 5 year average	-
Net Income/employee - most recent fiscal year	-2,36,212.00
Return on average equity - trailing 12 month	26.26
Receivables turnover - trailing 12 month	-
Asset turnover - most recent fiscal year	0.00
Asset turnover - trailing 12 month	0.00
Return on average equity - most recent fiscal year	-5.11
Return on investment - 5 year average	-